Clinical trial · Interventional
Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
Registry Protocol for Tracking the Incidence of Transplant, the Incidence and Type of Cancer, and Survival Rate of Subjects Participating in Protocol VTI-206 (NCT00973817)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Subjects from lead-in study VTI-206 - NCT00973817 lost to follow-up before enrollment in VTI-207 (NCT1452295)
Summary
Brief summary (as posted)
VTI-207 (NCT01452295) is designed to follow subjects, both treated and control, for five years after their completion of study participation in protocol VTI-206 (NCT00973817) to gather information relating to the incidence of liver transplant, the incidence and type of cancer (if any), and survival.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Liver Failure | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ELAD (Extracorporeal Liver Assist System) | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- AOCH patients
- description
- Patients with acute on chronic hepatitis
- interventionNames
- Drug: ELAD (Extracorporeal Liver Assist System)
- type
- EXPERIMENTAL
- label
- AAH patients
- description
- Patients with acute alcoholic hepatitis
- interventionNames
- Drug: ELAD (Extracorporeal Liver Assist System)
Primary outcomes (1)
- measure
- Gather data
- timeFrame
- Five years post study participation
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects participating in the VTI-206 clinical trial. Exclusion Criteria: * Subjects not participating in the VTI-206 clinical trial.
References
Publications (0)
Data not yet available